Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
PubMed 18061177 PMC2431115 TB-4 / TB-500 product mislabeling documented bidirectional mislabeling between full-length TB-4 (43 aa) and the TB-500 fragment (residues 1723) in marketed peptide products: Esposito M et al
Informed decisions support safer purchasing and responsible medical usage practices
A high number driven by intake is therefore a bookkeeping observation, not a health problem
For competitive or endurance athletes facing tight recovery windows, this multi-nutrient approach accelerates the return to peak readiness
Modifier usage with 96372 Several modifiers may apply to 96372 depending on the clinical scenario
Common themes include rapid onset of anti-inflammatory effects (often within days), gradual improvement in function over weeks, and best results when combined with appropriate physical therapy and lifestyle modifications
